Genomic Medicine
Studying how genomic sequencing can be integrated into clinical care for healthy individuals and families.
Welcome
Welcome! I am an Associate Professor of Population Medicine at the Harvard Pilgrim Health Care Institute and Harvard Medical School, and Associate Director of the Precision Medicine Translational Research Center (PROMoTeR). My research focuses on the clinical, behavioral, and economic impact of genomic medicine, with an emphasis on integrating genomic sequencing into health care in ways that improve patient outcomes and inform health policy.
News
- June 2026
This website is being updated. Thank you for your patience.
- June 2026
I'm delighted to announce that our research team will be collaborating on the newly funded study titled PopScreen, short for Population Genomic Screening in Primary Care. This effort is one of a network of NIH-funded programs to develop and evaluate scalable approaches to offering population-based genetic testing to broad adult populations.
Current Research Programs
LIVINGEvaluating long-term outcomes and value of infant genomic sequencing.PreEMPTModeling the clinical and economic value of newborn genomic screening.PopScreenImplementing population genomic screening in primary care.BabySeqImplementing genome sequencing as screening in a diverse cohort of healthy infants.Breast Cancer Prevention ModelingEstimating benefits and harms of risk-reducing medications for high-risk survivors.
Research Interests
Research Highlights
Health Economics
Evaluating value, costs, and policy implications of genomic technologies in health care settings.
Behavioral Outcomes
Examining psychosocial, behavioral, and provider outcomes associated with clinical and consumer genomic testing.